Kwang Dong made registration of patent with Kyungokko in Japan for prevention and treatment of male infertility
Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 21st that Kyungokko KwangDong, which has been exported to Japan, registered a patent(No. JP6063499, expiring on Feb 27 2035) at the Japan Patent Office as it was studied to have efficacy in prevention and treatment of male infertility....
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
